Fig. 2From: Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathwayTotal cholesterol and triglyceride levels of fast performance liquid chromatography (FPLC) fractions. The graph shows a cholesterol and b triglyceride concentrations of FPLC fractions from pooled serum. Zn(ASA) 2 indicates a zinc complex of acetylsalicylic acid, ZDF Zucker diabetic fatty rats, ZL Zucker lean, VLDL very low density lipoprotein, LDL low density lipoprotein, HDL high density lipoproteinBack to article page